Literature DB >> 7521737

Adhesion molecule expression (ICAM-1, VCAM-1, E-selectin and PECAM) in human kidney allografts.

P Gibbs1, L M Berkley, E M Bolton, J D Briggs, J A Bradley.   

Abstract

Expression of the cellular adhesion molecules ICAM-1, VCAM-1, E-selectin and PECAM in human kidney allografts was assessed by immunoperoxidase labelling of cryostat sections. Biopsies from 10 kidneys immediately prior to transplantation and 58 biopsies from 51 kidney transplants with graft dysfunction were studied. Allograft dysfunction was due to acute tubular necrosis (n = 5), acute rejection (n = 30), cyclosporin A (CyA) nephrotoxicity (n = 6), acute pyelonephritis (n = 3), recurrent glomerulonephritis (n = 4) and chronic rejection (n = 10). There was variability in the distribution of ICAM-1, VCAM-1 and E-selectin expression in pretransplant kidneys but the principal observation was a marked increase in the expression of ICAM-1 and VCAM-1 by the renal vasculature and the proximal tubules during acute rejection. By contrast, grafts with dysfunction not attributed to rejection showed a pattern of ICAM-1 and VCAM-1 expression similar to that observed prior to transplantation. E-selectin was expressed only weakly by occasional intertubular capillaries during acute rejection but the three grafts with pyelonephritis displayed strong expression of E-selectin on intertubular capillaries. There was no change in the pattern of PECAM expression following transplantation. The induction of ICAM-1 and VCAM-1 during rejection may contribute to the recruitment of mononuclear cells and render endothelial and tubular renal cells more susceptible to cell-mediated injury.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7521737     DOI: 10.1016/0966-3274(93)90003-q

Source DB:  PubMed          Journal:  Transpl Immunol        ISSN: 0966-3274            Impact factor:   1.708


  7 in total

1.  Accelerated atheromatous lesions in mouse hearts transplanted to apolipoprotein-E-deficient recipients.

Authors:  P S Russell; C M Chase; R B Colvin
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

2.  Leukocyte integrin Mac-1 promotes acute cardiac allograft rejection.

Authors:  Koichi Shimizu; Peter Libby; Rica Shubiki; Masashi Sakuma; Yunmei Wang; Kenichi Asano; Richard N Mitchell; Daniel I Simon
Journal:  Circulation       Date:  2008-03-31       Impact factor: 29.690

3.  Low-dose carbon monoxide inhibits progressive chronic allograft nephropathy and restores renal allograft function.

Authors:  Atsunori Nakao; Gaetano Faleo; Michael A Nalesnik; Joao Seda-Neto; Junichi Kohmoto; Noriko Murase
Journal:  Am J Physiol Renal Physiol       Date:  2009-04-15

4.  Acute Kidney Injury in Children after Hematopoietic Cell Transplantation Is Associated with Elevated Urine CXCL10 and CXCL9.

Authors:  Daniella Levy Erez; Michelle R Denburg; Simisola Afolayan; Sonata Jodele; Gregory Wallace; Stella M Davies; Alix E Seif; Nancy Bunin; Benjamin L Laskin; Kathleen E Sullivan
Journal:  Biol Blood Marrow Transplant       Date:  2020-03-09       Impact factor: 5.742

5.  Immunohistochemical study for the expression of leukocyte adhesion molecules, and FGF23 and ACE2 in P. gingivalis LPS-induced diabetic nephropathy.

Authors:  Koichiro Kajiwara; Yoshihiko Sawa; Takahiro Fujita; Sachio Tamaoki
Journal:  BMC Nephrol       Date:  2021-01-06       Impact factor: 2.388

6.  An enhanced level of VCAM in transplant preservation fluid is an independent predictor of early kidney allograft dysfunction.

Authors:  Michael Baboudjian; Bastien Gondran-Tellier; Romain Boissier; Patricia Ancel; Juline Marjollet; Luc Lyonnet; Pauline François; Florence Sabatier; Eric Lechevallier; Anne Dutour; Pascale Paul
Journal:  Front Immunol       Date:  2022-08-11       Impact factor: 8.786

7.  Enhanced protection of the renal vascular endothelium improves early outcome in kidney transplantation: Preclinical investigations in pig and mouse.

Authors:  Sofia Nordling; Johan Brännström; Fredrik Carlsson; Bo Lu; Evelyn Salvaris; Alkwin Wanders; Jos Buijs; Sergio Estrada; Vladimir Tolmachev; Peter J Cowan; Tomas Lorant; Peetra U Magnusson
Journal:  Sci Rep       Date:  2018-03-26       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.